You are here

Our science / Clinical Trials / Find a Trial / NCT00334750

Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada

Back to Search Print Save as PDF Bookmark Trial

NCT00334750

Last updated on March 14, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
Calgary, Alberta, T3E 7M8 Canada
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Open-Angle Glaucoma, Ocular Hypertension
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Subjects diagnosed at study visit or within 3 months of visit with OH

- OAG (to include POAG, NTG, pigmentary and pseudoexfoliation glaucoma)

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- No prior treatment for OH or OAG

- No prior ocular surgery or history of ocular trauma

NCT00334750
Pfizer
Completed
Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now